January 4, 2011 -- San
Diego -- Volcano Corporation (Nasdaq: VOLC), a leading developer and
manufacturer of precision intravascular diagnosis and therapy
guidance tools designed to enhance the treatment of coronary
and peripheral vascular disease, said today that it will be participating
in the 29th Annual J.P. Morgan Healthcare Conference on Tuesday,
January 11.
The presentation by Scott Huennekens, president and chief
executive officer, will begin at 9 a.m., Pacific Standard Time
(12 p.m., Eastern
Standard Time). |